HB 2695 Text

President Majority Leader Members Committees District Maps Audio Senate Clerk Senate Rules

Speaker Members Committees District Maps Audio House Clerk House Rules

Interim Committees Budget & Fiscal Affairs Court of Claims Crime Victims LASD Legislative Services PERD Post Audit Public Information Rule-Making Review Special Investigations Joint Rules Staff Only

Bill Status

Bill Status Bill Tracking

WV Code

WV Code WV Constitution US Constitution

Audits/ Reports

State Agency Grant Awards State Agency Reports Legislative Audit Reports Post Audit Reports

Educational

Citizen’s Guide Internship Program Page Program Back to School Program Publications Capitol Photo Gallery Capitol History How a Bill Becomes Law

Contact

Senate Roster House Roster Public Information Webmaster Helpful Links

Introduced Version House Bill 2695 History

DOWNLOAD wpd |

hb2695 intr 206 CSR 1
H. B. 2695

(By Delegates Brown, Miley, Burdiss and Talbott)

[Introduced January 29, 2007; referred to the
Committee on Finance then the
Judiciary.]

A BILL to amend and reenact article 9, chapter 64 of the Code of West Virginia, 1931, as amended, relating to authorizing the West Virginia Pharmaceutical Cost Management Council to promulgate a legislative rule relating to pharmaceutical advertising expense reporting.

Be it enacted by the Legislature of West Virginia:
That article 9, chapter 64 of the Code of West Virginia, 1931, as amended, be amended and reenacted to read as follows:

ARTICLE 9. AUTHORIZATION FOR MISCELLANEOUS AGENCIES AND BOARDS TO PROMULGATE LEGISLATIVE RULES.

§64-9-1. Pharmaceutical Cost Management Council .
The legislative rule filed in the state register on the twenty-eighth day of July, two thousand six, authorized under the authority of section thirteen, article three-C, chapter five-A, of this code, modified by the West Virginia Pharmaceutical Cost Management Council to meet the objections of the legislative rule- making review committee and refiled in the state register on the seventeenth day of January, two thousand six, relating to the Office of the Pharmaceutical Advocate (pharmaceutical advertising expense reporting, 206 CSR 1), is authorized with the amendment set forth below:
on page 2, subsection 3.1, line 1, by striking out the words "After the effective date of these rules" and inserting in lieu thereof the words "Effective July 1, 2008".

NOTE: The purpose of this bill is to authorize the West Virginia Pharmaceutical Cost Management Council to promulgate a legislative rule relating to Pharmaceutical Advertising Expense Reporting.

This section is new; therefore, strike-throughs and underscoring have been omitted.